spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  peritoneal dialysis 

 HSMN NewsFeed - 3 Dec 2024
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Devices Interventional Product Launch
 HSMN NewsFeed - 28 May 2024
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
Devices Monitoring FDA
 HSMN NewsFeed - 22 Feb 2022
MicroVention Announces First U.S. Patient Treated with FRED(TM) X(TM) Flow Diverter Featuring X Technology
Devices Interventional Neurosurgery
 HSMN NewsFeed - 14 Jul 2021
Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
Devices Interventional Product Launch
 HSMN NewsFeed - 12 Jan 2021
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
Devices Neurosurgery FDA
 HSMN NewsFeed - 5 Jan 2021
Terumo Enters 100th Anniversary Year
Devices
 HSMN NewsFeed - 5 May 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Biopharmaceuticals
 HSMN NewsFeed - 3 Nov 2015
Debiotech and Fresenius Medical Care Announce Exclusive Partnership for New Home Dialysis Product Development
Devices
 HSMN NewsFeed - 13 Oct 2015
Baxter Announces U.S. FDA Clearance for AMIA Automated Peritoneal Dialysis System with SHARESOURCE Connectivity Platform
Devices FDA
 HSMN NewsFeed - 8 Apr 2014
Fresenius Medical Care Renal Therapies Group Announces Chief Medical Officer to Retire
Devices Personnel
 HSMN NewsFeed - 12 Dec 2013
CorMedix Announces First Sales of Neutrolin(R) in the European Union
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 9 Oct 2013
Apollo Hospitals and Medtronic Announce a Collaboration to Bring an Affordable, Portable Hemodialysis System to India
Devices
 HSMN NewsFeed - 6 Sep 2013
Baxter Completes Acquisition of Gambro AB and Enhances Global Leadership in Renal Therapies
Devices Mergers & Acquisitions
 HSMN NewsFeed - 19 Jun 2013
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza(R) (saxagliptin)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Apr 2013
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 9 Jan 2013
Velomedix Receives Health Canada Approval for VELOCITY Pilot Study and Bolsters Leadership Team
Devices Cardiology Regulatory
 HSMN NewsFeed - 6 Jan 2013
AWAK Technologies Enters into an Exclusive Agreement with Baxter International for the Development of Wearable Dialysis Technology
Devices
 HSMN NewsFeed - 4 Dec 2012
Baxter Enhances Renal Therapies Portfolio with Acquisition of Gambro
Devices Mergers & Acquisitions
 HSMN NewsFeed - 29 Nov 2012
Merit Medical Acquires Assets of Medigroup
Devices Interventional Acquisitions
 HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Devices Personnel
 HSMN NewsFeed - 18 Oct 2010
U.S. Food and Drug Administration Approves BARACLUDE(R) (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jul 2010
Fresenius Medical Care Enters into Long-Term Distribution Agreement in Japan and Expands Dialysis Products Business in Korea
Devices Distribution
 HSMN NewsFeed - 9 Mar 2010
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 2 Mar 2010
FDA Classifies Baxter's January HomeChoice Peritoneal Dialysis Cycler Field Corrective Action as a Class I Recall
Devices Product Recall FDA
 HSMN NewsFeed - 20 Jan 2010
Gambro Announces Agreement to Acquire CHF Solutions, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 28 Oct 2009
Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Biopharmaceuticals
 HSMN NewsFeed - 23 Mar 2009
Dialysis is Changing: New Treatment Options Offer Patients Greater Flexibility and Control over Lifestyle
Devices
 HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Mar 2008
A Peritoneal-Based Wearable Artificial Kidney for Continuous Dialysis of Patients with End-Stage Renal Disease
Devices Licensing
 HSMN NewsFeed - 25 Jan 2008
Ash Access Technology and Commercial Partner AngioDynamics Highlight Results From Preliminary Study of Centros(TM)
Devices
 HSMN NewsFeed - 24 Jan 2008
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
Biopharmaceuticals Devices
 HSMN NewsFeed - 17 Jan 2008
Ash Access Technology, Inc. Partners With AngioDynamics to Launch Innovative Central Venous Catheter for Hemodialysis
Devices
 HSMN NewsFeed - 22 Oct 2007
FDA Approves Genzyme's Renvela(TM) for Dialysis Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Oct 2007
FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin)
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 18 Sep 2007
One-Year Data Showed Investigational Use of Initial Combination Therapy with JANUVIA(TM) (sitagliptin) and Metformin Significantly Improved Blood Sugar Control in Patients with Type 2 Diabetes Compared to Metformin Alone
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 6 Aug 2007
Baxter Announces Collaboration for Development of Next-Generation Home Hemodialysis Machine
Devices
 HSMN NewsFeed - 9 Jul 2007
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
Devices Personnel
 HSMN NewsFeed - 5 Mar 2007
UK Launch Expands Global Reach of FOSRENOL(R)
Biopharmaceuticals
 HSMN NewsFeed - 1 Dec 2006
Merck Announces JANUMET(TM), the Trademark for its Investigational Combination Therapy of Sitagliptin Phosphate and Metformin for Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 17 Oct 2006
FDA Approves Once-Daily JANUVIA(TM), the First and Only DPP-4 Inhibitor Available in the United States for Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 16 Jul 2006
Amgen Announces EVOLVE Trial(TM) To Investigate Impact of Sensipar(R)/Mimpara(R) (cinacalcet HCl) on Mortality and Cardiovascular Morbidity in Secondary Hyperparathyroidism Patients With Chronic Kidney Disease Receiving Dialysis
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 20

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 20 additional stories matching:
peritoneal dialysis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.